The global market for Crohn’s Disease Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Crohn’s disease (CD) is a form of inflammatory bowel disease (IBD), which is comprised of two chronic autoimmune diseases that cause intestinal inflammation: Crohn’s disease (CD) and ulcerative colitis (UC). The pathophysiology of CD is complex, as the disease is characterized by recurring flares that evolve along with periods of inactivity and remission.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Crohn’s Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crohn’s Disease Drugs.

The Crohn’s Disease Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Crohn’s Disease Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Crohn’s Disease Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Crohn’s Disease Drugs Market Report

Report Metric	Details
Report Name	Crohn’s Disease Drugs Market
CAGR	5%
Segment by Type	Anti-Inflammatory Immune system suppressors Antibiotics Others
Segment by Application	Hospitals Clinics Hospitalshospital Pharmacies Retail Pharmacies Online Pharmacies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Bayer AG, Amgen, Takeda Pharmaceutical, AbbVie, UCB, Ferring, Eli Lilly, Hoffman-La Roche, Bristol-Myers Squibb, Pfizer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Crohn’s Disease Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Crohn’s Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Crohn’s Disease Drugs Market report?

Ans: The main players in the Crohn’s Disease Drugs Market are Bayer AG, Amgen, Takeda Pharmaceutical, AbbVie, UCB, Ferring, Eli Lilly, Hoffman-La Roche, Bristol-Myers Squibb, Pfizer

What are the Application segmentation covered in the Crohn’s Disease Drugs Market report?

Ans: The Applications covered in the Crohn’s Disease Drugs Market report are Hospitals, Clinics, Hospitalshospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Crohn’s Disease Drugs Market report?

Ans: The Types covered in the Crohn’s Disease Drugs Market report are Anti-Inflammatory, Immune system suppressors, Antibiotics, Others

1 Crohn’s Disease Drugs Market Overview

1.1 Product Definition

1.2 Crohn’s Disease Drugs by Type

1.2.1 Global Crohn’s Disease Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Anti-Inflammatory

1.2.3 Immune system suppressors

1.2.4 Antibiotics

1.2.5 Others

1.3 Crohn’s Disease Drugs by Application

1.3.1 Global Crohn’s Disease Drugs Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Hospitalshospital Pharmacies

1.3.5 Retail Pharmacies

1.3.6 Online Pharmacies

1.4 Global Crohn’s Disease Drugs Market Size Estimates and Forecasts

1.4.1 Global Crohn’s Disease Drugs Revenue 2020-2031

1.4.2 Global Crohn’s Disease Drugs Sales 2020-2031

1.4.3 Global Crohn’s Disease Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Crohn’s Disease Drugs Market Competition by Manufacturers

2.1 Global Crohn’s Disease Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Crohn’s Disease Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Crohn’s Disease Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Crohn’s Disease Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Crohn’s Disease Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Crohn’s Disease Drugs, Product Type & Application

2.7 Global Key Manufacturers of Crohn’s Disease Drugs, Date of Enter into This Industry

2.8 Global Crohn’s Disease Drugs Market Competitive Situation and Trends

2.8.1 Global Crohn’s Disease Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Crohn’s Disease Drugs Players Market Share by Revenue

2.8.3 Global Crohn’s Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Crohn’s Disease Drugs Market Scenario by Region

3.1 Global Crohn’s Disease Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Crohn’s Disease Drugs Sales by Region: 2020-2031

3.2.1 Global Crohn’s Disease Drugs Sales by Region: 2020-2025

3.2.2 Global Crohn’s Disease Drugs Sales by Region: 2026-2031

3.3 Global Crohn’s Disease Drugs Revenue by Region: 2020-2031

3.3.1 Global Crohn’s Disease Drugs Revenue by Region: 2020-2025

3.3.2 Global Crohn’s Disease Drugs Revenue by Region: 2026-2031

3.4 North America Crohn’s Disease Drugs Market Facts & Figures by Country

3.4.1 North America Crohn’s Disease Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Crohn’s Disease Drugs Sales by Country (2020-2031)

3.4.3 North America Crohn’s Disease Drugs Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Crohn’s Disease Drugs Market Facts & Figures by Country

3.5.1 Europe Crohn’s Disease Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Crohn’s Disease Drugs Sales by Country (2020-2031)

3.5.3 Europe Crohn’s Disease Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Crohn’s Disease Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Crohn’s Disease Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Crohn’s Disease Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Crohn’s Disease Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Crohn’s Disease Drugs Market Facts & Figures by Country

3.7.1 Latin America Crohn’s Disease Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Crohn’s Disease Drugs Sales by Country (2020-2031)

3.7.3 Latin America Crohn’s Disease Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Crohn’s Disease Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Crohn’s Disease Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Crohn’s Disease Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Crohn’s Disease Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Crohn’s Disease Drugs Sales by Type (2020-2031)

4.1.1 Global Crohn’s Disease Drugs Sales by Type (2020-2025)

4.1.2 Global Crohn’s Disease Drugs Sales by Type (2026-2031)

4.1.3 Global Crohn’s Disease Drugs Sales Market Share by Type (2020-2031)

4.2 Global Crohn’s Disease Drugs Revenue by Type (2020-2031)

4.2.1 Global Crohn’s Disease Drugs Revenue by Type (2020-2025)

4.2.2 Global Crohn’s Disease Drugs Revenue by Type (2026-2031)

4.2.3 Global Crohn’s Disease Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Crohn’s Disease Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Crohn’s Disease Drugs Sales by Application (2020-2031)

5.1.1 Global Crohn’s Disease Drugs Sales by Application (2020-2025)

5.1.2 Global Crohn’s Disease Drugs Sales by Application (2026-2031)

5.1.3 Global Crohn’s Disease Drugs Sales Market Share by Application (2020-2031)

5.2 Global Crohn’s Disease Drugs Revenue by Application (2020-2031)

5.2.1 Global Crohn’s Disease Drugs Revenue by Application (2020-2025)

5.2.2 Global Crohn’s Disease Drugs Revenue by Application (2026-2031)

5.2.3 Global Crohn’s Disease Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Crohn’s Disease Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Bayer AG

6.1.1 Bayer AG Company Information

6.1.2 Bayer AG Description and Business Overview

6.1.3 Bayer AG Crohn’s Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Bayer AG Crohn’s Disease Drugs Product Portfolio

6.1.5 Bayer AG Recent Developments/Updates

6.2 Amgen

6.2.1 Amgen Company Information

6.2.2 Amgen Description and Business Overview

6.2.3 Amgen Crohn’s Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Amgen Crohn’s Disease Drugs Product Portfolio

6.2.5 Amgen Recent Developments/Updates

6.3 Takeda Pharmaceutical

6.3.1 Takeda Pharmaceutical Company Information

6.3.2 Takeda Pharmaceutical Description and Business Overview

6.3.3 Takeda Pharmaceutical Crohn’s Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Takeda Pharmaceutical Crohn’s Disease Drugs Product Portfolio

6.3.5 Takeda Pharmaceutical Recent Developments/Updates

6.4 AbbVie

6.4.1 AbbVie Company Information

6.4.2 AbbVie Description and Business Overview

6.4.3 AbbVie Crohn’s Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 AbbVie Crohn’s Disease Drugs Product Portfolio

6.4.5 AbbVie Recent Developments/Updates

6.5 UCB

6.5.1 UCB Company Information

6.5.2 UCB Description and Business Overview

6.5.3 UCB Crohn’s Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 UCB Crohn’s Disease Drugs Product Portfolio

6.5.5 UCB Recent Developments/Updates

6.6 Ferring

6.6.1 Ferring Company Information

6.6.2 Ferring Description and Business Overview

6.6.3 Ferring Crohn’s Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Ferring Crohn’s Disease Drugs Product Portfolio

6.6.5 Ferring Recent Developments/Updates

6.7 Eli Lilly

6.7.1 Eli Lilly Company Information

6.7.2 Eli Lilly Description and Business Overview

6.7.3 Eli Lilly Crohn’s Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Eli Lilly Crohn’s Disease Drugs Product Portfolio

6.7.5 Eli Lilly Recent Developments/Updates

6.8 Hoffman-La Roche

6.8.1 Hoffman-La Roche Company Information

6.8.2 Hoffman-La Roche Description and Business Overview

6.8.3 Hoffman-La Roche Crohn’s Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Hoffman-La Roche Crohn’s Disease Drugs Product Portfolio

6.8.5 Hoffman-La Roche Recent Developments/Updates

6.9 Bristol-Myers Squibb

6.9.1 Bristol-Myers Squibb Company Information

6.9.2 Bristol-Myers Squibb Description and Business Overview

6.9.3 Bristol-Myers Squibb Crohn’s Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Bristol-Myers Squibb Crohn’s Disease Drugs Product Portfolio

6.9.5 Bristol-Myers Squibb Recent Developments/Updates

6.10 Pfizer

6.10.1 Pfizer Company Information

6.10.2 Pfizer Description and Business Overview

6.10.3 Pfizer Crohn’s Disease Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Pfizer Crohn’s Disease Drugs Product Portfolio

6.10.5 Pfizer Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Crohn’s Disease Drugs Industry Chain Analysis

7.2 Crohn’s Disease Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Crohn’s Disease Drugs Production Mode & Process Analysis

7.4 Crohn’s Disease Drugs Sales and Marketing

7.4.1 Crohn’s Disease Drugs Sales Channels

7.4.2 Crohn’s Disease Drugs Distributors

7.5 Crohn’s Disease Drugs Customer Analysis

8 Crohn’s Disease Drugs Market Dynamics

8.1 Crohn’s Disease Drugs Industry Trends

8.2 Crohn’s Disease Drugs Market Drivers

8.3 Crohn’s Disease Drugs Market Challenges

8.4 Crohn’s Disease Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bayer

Amgen Inc

Takeda Pharmaceutical

List of Tables

Table 1. Global Crohn’s Disease Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Crohn’s Disease Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Crohn’s Disease Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Crohn’s Disease Drugs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Crohn’s Disease Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Crohn’s Disease Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Crohn’s Disease Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Crohn’s Disease Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Crohn’s Disease Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Crohn’s Disease Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Crohn’s Disease Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Crohn’s Disease Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Crohn’s Disease Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Crohn’s Disease Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Crohn’s Disease Drugs Sales by Region (2020-2025) & (K Units)

Table 18. Global Crohn’s Disease Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Crohn’s Disease Drugs Sales by Region (2026-2031) & (K Units)

Table 20. Global Crohn’s Disease Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Crohn’s Disease Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Crohn’s Disease Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Crohn’s Disease Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Crohn’s Disease Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Crohn’s Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Crohn’s Disease Drugs Sales by Country (2020-2025) & (K Units)

Table 27. North America Crohn’s Disease Drugs Sales by Country (2026-2031) & (K Units)

Table 28. North America Crohn’s Disease Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Crohn’s Disease Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Crohn’s Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Crohn’s Disease Drugs Sales by Country (2020-2025) & (K Units)

Table 32. Europe Crohn’s Disease Drugs Sales by Country (2026-2031) & (K Units)

Table 33. Europe Crohn’s Disease Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Crohn’s Disease Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Crohn’s Disease Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Crohn’s Disease Drugs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Crohn’s Disease Drugs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Crohn’s Disease Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Crohn’s Disease Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Crohn’s Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Crohn’s Disease Drugs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Crohn’s Disease Drugs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Crohn’s Disease Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Crohn’s Disease Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Crohn’s Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Crohn’s Disease Drugs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Crohn’s Disease Drugs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Crohn’s Disease Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Crohn’s Disease Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Crohn’s Disease Drugs Sales (K Units) by Type (2020-2025)

Table 51. Global Crohn’s Disease Drugs Sales (K Units) by Type (2026-2031)

Table 52. Global Crohn’s Disease Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Crohn’s Disease Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Crohn’s Disease Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Crohn’s Disease Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Crohn’s Disease Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Crohn’s Disease Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Crohn’s Disease Drugs Price (USD/Unit) by Type (2020-2025)

Table 59. Global Crohn’s Disease Drugs Price (USD/Unit) by Type (2026-2031)

Table 60. Global Crohn’s Disease Drugs Sales (K Units) by Application (2020-2025)

Table 61. Global Crohn’s Disease Drugs Sales (K Units) by Application (2026-2031)

Table 62. Global Crohn’s Disease Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Crohn’s Disease Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Crohn’s Disease Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Crohn’s Disease Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Crohn’s Disease Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Crohn’s Disease Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Crohn’s Disease Drugs Price (USD/Unit) by Application (2020-2025)

Table 69. Global Crohn’s Disease Drugs Price (USD/Unit) by Application (2026-2031)

Table 70. Bayer AG Company Information

Table 71. Bayer AG Description and Business Overview

Table 72. Bayer AG Crohn’s Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Bayer AG Crohn’s Disease Drugs Product

Table 74. Bayer AG Recent Developments/Updates

Table 75. Amgen Company Information

Table 76. Amgen Description and Business Overview

Table 77. Amgen Crohn’s Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Amgen Crohn’s Disease Drugs Product

Table 79. Amgen Recent Developments/Updates

Table 80. Takeda Pharmaceutical Company Information

Table 81. Takeda Pharmaceutical Description and Business Overview

Table 82. Takeda Pharmaceutical Crohn’s Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Takeda Pharmaceutical Crohn’s Disease Drugs Product

Table 84. Takeda Pharmaceutical Recent Developments/Updates

Table 85. AbbVie Company Information

Table 86. AbbVie Description and Business Overview

Table 87. AbbVie Crohn’s Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. AbbVie Crohn’s Disease Drugs Product

Table 89. AbbVie Recent Developments/Updates

Table 90. UCB Company Information

Table 91. UCB Description and Business Overview

Table 92. UCB Crohn’s Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. UCB Crohn’s Disease Drugs Product

Table 94. UCB Recent Developments/Updates

Table 95. Ferring Company Information

Table 96. Ferring Description and Business Overview

Table 97. Ferring Crohn’s Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Ferring Crohn’s Disease Drugs Product

Table 99. Ferring Recent Developments/Updates

Table 100. Eli Lilly Company Information

Table 101. Eli Lilly Description and Business Overview

Table 102. Eli Lilly Crohn’s Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Eli Lilly Crohn’s Disease Drugs Product

Table 104. Eli Lilly Recent Developments/Updates

Table 105. Hoffman-La Roche Company Information

Table 106. Hoffman-La Roche Description and Business Overview

Table 107. Hoffman-La Roche Crohn’s Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Hoffman-La Roche Crohn’s Disease Drugs Product

Table 109. Hoffman-La Roche Recent Developments/Updates

Table 110. Bristol-Myers Squibb Company Information

Table 111. Bristol-Myers Squibb Description and Business Overview

Table 112. Bristol-Myers Squibb Crohn’s Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Bristol-Myers Squibb Crohn’s Disease Drugs Product

Table 114. Bristol-Myers Squibb Recent Developments/Updates

Table 115. Pfizer Company Information

Table 116. Pfizer Description and Business Overview

Table 117. Pfizer Crohn’s Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Pfizer Crohn’s Disease Drugs Product

Table 119. Pfizer Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Crohn’s Disease Drugs Distributors List

Table 123. Crohn’s Disease Drugs Customers List

Table 124. Crohn’s Disease Drugs Market Trends

Table 125. Crohn’s Disease Drugs Market Drivers

Table 126. Crohn’s Disease Drugs Market Challenges

Table 127. Crohn’s Disease Drugs Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Crohn’s Disease Drugs

Figure 2. Global Crohn’s Disease Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Crohn’s Disease Drugs Market Share by Type: 2024 & 2031

Figure 4. Anti-Inflammatory Product Picture

Figure 5. Immune system suppressors Product Picture

Figure 6. Antibiotics Product Picture

Figure 7. Others Product Picture

Figure 8. Global Crohn’s Disease Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Crohn’s Disease Drugs Market Share by Application: 2024 & 2031

Figure 10. Hospitals

Figure 11. Clinics

Figure 12. Hospitalshospital Pharmacies

Figure 13. Retail Pharmacies

Figure 14. Online Pharmacies

Figure 15. Global Crohn’s Disease Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Crohn’s Disease Drugs Market Size (2020-2031) & (US$ Million)

Figure 17. Global Crohn’s Disease Drugs Sales (2020-2031) & (K Units)

Figure 18. Global Crohn’s Disease Drugs Average Price (USD/Unit) & (2020-2031)

Figure 19. Crohn’s Disease Drugs Report Years Considered

Figure 20. Crohn’s Disease Drugs Sales Share by Manufacturers in 2024

Figure 21. Global Crohn’s Disease Drugs Revenue Share by Manufacturers in 2024

Figure 22. Global 5 and 10 Largest Crohn’s Disease Drugs Players: Market Share by Revenue in Crohn’s Disease Drugs in 2024

Figure 23. Crohn’s Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 24. Global Crohn’s Disease Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 25. North America Crohn’s Disease Drugs Sales Market Share by Country (2020-2031)

Figure 26. North America Crohn’s Disease Drugs Revenue Market Share by Country (2020-2031)

Figure 27. U.S. Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Canada Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Europe Crohn’s Disease Drugs Sales Market Share by Country (2020-2031)

Figure 30. Europe Crohn’s Disease Drugs Revenue Market Share by Country (2020-2031)

Figure 31. Germany Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. France Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. U.K. Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Italy Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Russia Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Asia Pacific Crohn’s Disease Drugs Sales Market Share by Region (2020-2031)

Figure 37. Asia Pacific Crohn’s Disease Drugs Revenue Market Share by Region (2020-2031)

Figure 38. China Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Japan Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. South Korea Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. India Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Australia Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Taiwan Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Indonesia Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Thailand Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Malaysia Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Philippines Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Latin America Crohn’s Disease Drugs Sales Market Share by Country (2020-2031)

Figure 49. Latin America Crohn’s Disease Drugs Revenue Market Share by Country (2020-2031)

Figure 50. Mexico Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Brazil Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Argentina Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Middle East and Africa Crohn’s Disease Drugs Sales Market Share by Country (2020-2031)

Figure 54. Middle East and Africa Crohn’s Disease Drugs Revenue Market Share by Country (2020-2031)

Figure 55. Turkey Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Saudi Arabia Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. U.A.E Crohn’s Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Global Sales Market Share of Crohn’s Disease Drugs by Type (2020-2031)

Figure 59. Global Revenue Market Share of Crohn’s Disease Drugs by Type (2020-2031)

Figure 60. Global Crohn’s Disease Drugs Price (USD/Unit) by Type (2020-2031)

Figure 61. Global Sales Market Share of Crohn’s Disease Drugs by Application (2020-2031)

Figure 62. Global Revenue Market Share of Crohn’s Disease Drugs by Application (2020-2031)

Figure 63. Global Crohn’s Disease Drugs Price (USD/Unit) by Application (2020-2031)

Figure 64. Crohn’s Disease Drugs Value Chain

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32P14840

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-20V18395

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32G20014

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9U20281

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions